Similar Items
BMW: Bayesian Model-Assisted Adaptive Phase II Clinical Trial Design for Win Ratio Statistic
by: Zhu, Di, et al.
Published: (2026)
by: Zhu, Di, et al.
Published: (2026)
A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
by: Komaki, Moka, et al.
Published: (2025)
by: Komaki, Moka, et al.
Published: (2025)
TITE-STEIN: Time-to-event Simple Toxicity and Efficacy Interval Design to Accelerate Phase I/II Trials
by: Sun, Hao, et al.
Published: (2025)
by: Sun, Hao, et al.
Published: (2025)
The Win Ratio at the Design Stage of Clinical Trials
by: Kronthaler, David, et al.
Published: (2025)
by: Kronthaler, David, et al.
Published: (2025)
Design of Bayesian Clinical Trials with Clustered Data
by: Hagar, Luke, et al.
Published: (2025)
by: Hagar, Luke, et al.
Published: (2025)
Seamless Phase I--II Cancer Clinical Trials Using Kernel-Based Covariate Similarity
by: Makino, Kana, et al.
Published: (2025)
by: Makino, Kana, et al.
Published: (2025)
Toxicity Monitoring Rule for a Two-Cohort Phase II Clinical Trial with Bivariate Beta Prior
by: Wang, Yu, et al.
Published: (2026)
by: Wang, Yu, et al.
Published: (2026)
A Bayesian Discrete Framework for Enhancing Decision-Making Processes in Clinical Trial Designs and Evaluations
by: Pramanik, Paramahansa, et al.
Published: (2026)
by: Pramanik, Paramahansa, et al.
Published: (2026)
ROMI: A Randomized Two-Stage Basket Trial Design to Optimize Doses for Multiple Indications
by: Wang, Shuqi, et al.
Published: (2024)
by: Wang, Shuqi, et al.
Published: (2024)
Some Bayesian Perspectives on Clinical Trials
by: Sokolova, Alexandra, et al.
Published: (2026)
by: Sokolova, Alexandra, et al.
Published: (2026)
A Two-Step Test to Identify Zero-Inflated Biomarkers in Early-Phase Clinical Trials
by: Xi, Nan Miles, et al.
Published: (2025)
by: Xi, Nan Miles, et al.
Published: (2025)
MUCE: Bayesian Hierarchical Modeling for the Design and Analysis of Phase 1b Multiple Expansion Cohort Trials
by: Lyu, Jiaying, et al.
Published: (2020)
by: Lyu, Jiaying, et al.
Published: (2020)
An Adaptive Phase II Trial Design for Dose Selection and Addition in Microfilarial Infections
by: Zehetmayer, Sonja, et al.
Published: (2026)
by: Zehetmayer, Sonja, et al.
Published: (2026)
Risk-inclusive Contextual Bandits for Early Phase Clinical Trials
by: Kanrar, Rohit, et al.
Published: (2025)
by: Kanrar, Rohit, et al.
Published: (2025)
Optimal Designs for Two-Stage Inference
by: Stallrich, Jonathan W., et al.
Published: (2023)
by: Stallrich, Jonathan W., et al.
Published: (2023)
A Class of Computational Methods to Reduce Selection Bias when Designing Phase 3 Clinical Trials
by: Zhan, Tianyu
Published: (2023)
by: Zhan, Tianyu
Published: (2023)
On the Calibration of Bayesian Success Criteria and Operating Characteristics for Clinical Trials
by: Yang, Peng, et al.
Published: (2026)
by: Yang, Peng, et al.
Published: (2026)
Partial Ordering Bayesian Logistic Regression Model for Phase I Combination Trials and Computationally Efficient Approach to Operational Prior Specification
by: Chen, Weishi, et al.
Published: (2024)
by: Chen, Weishi, et al.
Published: (2024)
Precision Dose-Finding Design for Phase I Oncology Trials by Integrating Pharmacology Data
by: Lee, Kyong Ju, et al.
Published: (2025)
by: Lee, Kyong Ju, et al.
Published: (2025)
Bayesian Event-Based Model for Disease Subtype and Stage Inference
by: Hao, Hongtao, et al.
Published: (2025)
by: Hao, Hongtao, et al.
Published: (2025)
BOIN Designs for Dose Escalation With Selected Dose Combinations in Oncology Phase I Trials
by: Chen, Yuxuan, et al.
Published: (2026)
by: Chen, Yuxuan, et al.
Published: (2026)
Using Model-Assisted Calibration Methods to Improve Efficiency of Regression Analyses with Two-Phase Samples under Complex Survey Designs
by: Wang, Lingxiao
Published: (2023)
by: Wang, Lingxiao
Published: (2023)
Estimating the Sampling Distribution of Posterior Decision Summaries in Bayesian Clinical Trials
by: Golchi, Shirin, et al.
Published: (2023)
by: Golchi, Shirin, et al.
Published: (2023)
A Two-Stage Bayesian Approach for Variable Selection in Joint Modeling of Multiple Longitudinal Markers with Competing Risks
by: Baghfalaki, Taban, et al.
Published: (2024)
by: Baghfalaki, Taban, et al.
Published: (2024)
Model-Assisted Bayesian Estimators of Transparent Population Level Summary Measures for Ordinal Outcomes in Randomized Controlled Trials
by: Turner, Lindsey E., et al.
Published: (2025)
by: Turner, Lindsey E., et al.
Published: (2025)
A Comparative Evaluation of Statistical Methods in Hybrid Controlled Trials
by: Ran, Di, et al.
Published: (2025)
by: Ran, Di, et al.
Published: (2025)
Bayesian Design and Analysis of Precision Trials with Partial Borrowing
by: Golchi, Shirin, et al.
Published: (2026)
by: Golchi, Shirin, et al.
Published: (2026)
An Efficient Approach to Design Bayesian Platform Trials
by: Hagar, Luke, et al.
Published: (2025)
by: Hagar, Luke, et al.
Published: (2025)
A Bayesian Optimal Phase II Design for Randomized Immunotherapy Trials with Delayed Treatment Effects
by: Cai, Zhongheng, et al.
Published: (2025)
by: Cai, Zhongheng, et al.
Published: (2025)
LORDs: Locally Optimal Restricted Designs for Phase I/II Dose-Finding Studies
by: Sverdlov, Oleksandr, et al.
Published: (2025)
by: Sverdlov, Oleksandr, et al.
Published: (2025)
Optimal Instrument Selection using Bayesian Model Averaging for Model Implied Instrumental Variable Two Stage Least Squares Estimators
by: Henry, Teague R., et al.
Published: (2018)
by: Henry, Teague R., et al.
Published: (2018)
Two-stage Adaptive Design Cluster Randomised Trials
by: Watson, Samuel I., et al.
Published: (2026)
by: Watson, Samuel I., et al.
Published: (2026)
Defining Utility as a Measure of Preference Under Uncertainty in Phase I-II Oncology Dose Finding Trials
by: Hall, Andrew, et al.
Published: (2025)
by: Hall, Andrew, et al.
Published: (2025)
A Workflow for Evaluating Regional Treatment Effect Heterogeneity in Multi-Regional Clinical Trials
by: Zhang, Cong, et al.
Published: (2026)
by: Zhang, Cong, et al.
Published: (2026)
Optimal sequential two-stage Bayes Factor Design for two-arm clinical Phase II Trials with binary Endpoints
by: Kelter, Riko
Published: (2026)
by: Kelter, Riko
Published: (2026)
Comparing HIV Vaccine Immunogenicity across Trials with Different Populations and Study Designs
by: Jin, Yutong, et al.
Published: (2024)
by: Jin, Yutong, et al.
Published: (2024)
Two-Stage Trigonometric Regression for Modeling Circadian Rhythms
by: Gorczyca, Michael T., et al.
Published: (2025)
by: Gorczyca, Michael T., et al.
Published: (2025)
SIMBA -- A Bayesian Decision Framework for the Identification of Optimal Biomarker Subgroups for Cancer Basket Clinical Trials
by: Yuan, Shijie, et al.
Published: (2025)
by: Yuan, Shijie, et al.
Published: (2025)
Priors from Envisioned Posterior Judgments: A Novel Elicitation Approach With Application to Bayesian Clinical Trials
by: Ouyang, Yongdong, et al.
Published: (2024)
by: Ouyang, Yongdong, et al.
Published: (2024)
Incertus.jl -- The Julia Lego Blocks for Randomized Clinical Trial Designs
by: Ryeznik, Yevgen, et al.
Published: (2024)
by: Ryeznik, Yevgen, et al.
Published: (2024)
Similar Items
-
BMW: Bayesian Model-Assisted Adaptive Phase II Clinical Trial Design for Win Ratio Statistic
by: Zhu, Di, et al.
Published: (2026) -
A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials
by: Komaki, Moka, et al.
Published: (2025) -
TITE-STEIN: Time-to-event Simple Toxicity and Efficacy Interval Design to Accelerate Phase I/II Trials
by: Sun, Hao, et al.
Published: (2025) -
The Win Ratio at the Design Stage of Clinical Trials
by: Kronthaler, David, et al.
Published: (2025) -
Design of Bayesian Clinical Trials with Clustered Data
by: Hagar, Luke, et al.
Published: (2025)